-
Signature
-
/s/ Julie Rogers, Attorney-in-Fact
-
Issuer symbol
-
RDDT
-
Transactions as of
-
17 Mar 2025
-
Net transactions value
-
-$4,173,990
-
Form type
-
4
-
Filing time
-
19 Mar 2025, 19:56:44 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RDDT |
Class A Common Stock |
Options Exercise |
$0 |
+33,333 |
+2.3% |
$0.000000 |
1,499,452 |
17 Mar 2025 |
Direct |
|
| transaction |
RDDT |
Class A Common Stock |
Sale |
$81,493 |
-675 |
-0.05% |
$120.73 |
1,498,777 |
17 Mar 2025 |
Direct |
F1, F2 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$559,106 |
-4,593 |
-0.31% |
$121.73 |
1,494,184 |
17 Mar 2025 |
Direct |
F1, F3 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$822,914 |
-6,710 |
-0.45% |
$122.64 |
1,487,474 |
17 Mar 2025 |
Direct |
F1, F4 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$368,076 |
-2,977 |
-0.2% |
$123.64 |
1,484,497 |
17 Mar 2025 |
Direct |
F1, F5 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$364,447 |
-2,924 |
-0.2% |
$124.64 |
1,481,573 |
17 Mar 2025 |
Direct |
F1, F6 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$1,033,505 |
-8,222 |
-0.55% |
$125.70 |
1,473,351 |
17 Mar 2025 |
Direct |
F1, F7 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$177,254 |
-1,400 |
-0.1% |
$126.61 |
1,471,951 |
17 Mar 2025 |
Direct |
F1, F8 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$281,402 |
-2,200 |
-0.15% |
$127.91 |
1,469,751 |
17 Mar 2025 |
Direct |
F1, F9 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$128,710 |
-1,000 |
-0.07% |
$128.71 |
1,468,751 |
17 Mar 2025 |
Direct |
F1, F10 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$51,920 |
-400 |
-0.03% |
$129.80 |
1,468,351 |
17 Mar 2025 |
Direct |
F1, F11 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$39,549 |
-300 |
-0.02% |
$131.83 |
1,468,051 |
17 Mar 2025 |
Direct |
F1, F12 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$13,302 |
-100 |
-0.01% |
$133.02 |
1,467,951 |
17 Mar 2025 |
Direct |
F1 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$40,359 |
-300 |
-0.02% |
$134.53 |
1,467,651 |
17 Mar 2025 |
Direct |
F1, F13 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$26,878 |
-198 |
-0.01% |
$135.75 |
1,467,453 |
17 Mar 2025 |
Direct |
F1, F14 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$41,151 |
-300 |
-0.02% |
$137.17 |
1,467,153 |
17 Mar 2025 |
Direct |
F1, F15 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$60,087 |
-434 |
-0.03% |
$138.45 |
1,466,719 |
17 Mar 2025 |
Direct |
F1, F16 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$69,745 |
-500 |
-0.03% |
$139.49 |
1,466,219 |
17 Mar 2025 |
Direct |
F1, F17 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$14,090 |
-100 |
-0.01% |
$140.90 |
1,466,119 |
17 Mar 2025 |
Direct |
F1 |
| holding |
RDDT |
Class A Common Stock |
|
|
|
|
|
161,000 |
17 Mar 2025 |
By MorMa Trust dated June 22, 2021 |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RDDT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-33,333 |
-6.6% |
$0.000000 |
469,787 |
17 Mar 2025 |
Class A Common Stock |
33,333 |
$5.35 |
Direct |
F18 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: